Sedadex
Dechra Introduces Sedadex
5 years ago 
2454 views
Dechra Veterinary Products has added the sedation and premedication product Sedadex® to its portfolio of anaesthesia and analgesia therapies.
Sedadex, which has the active ingredient dexmedetomidine, is indicated for sedation and analgesia and for premedication prior to general anaesthesia in dogs and cats. It comes in a 10 ml vial and has a 56-day broached shelf life.
Claire Morgan, Brand Manager from Dechra said: “Sedadex is a highly selective α2 adrenoceptor agonist that is licensed for intravenous or intramuscular use in dogs and intramuscular injection in cats.
“It is a welcome addition to Dechra’s anaesthesia and analgesia range and compliments our existing therapies that include Comfortan®, Sedator® and Atipam®”
For more information, go to www.dechra.co.uk
More from Dechra
- Dechra launches feline hyperthyroidism educational support
- ‘Bitesize’ canine Cushing’s syndrome webinar series now on Dechra Academy
- Dechra hosts strangles and equine disease management webinars
- Felimazole now available as an oral solution
- Dechra to host ‘bitesize’ canine Cushing’s syndrome CPD webinar series